We are live on ! Find out more
SIBN icon

SI-BONE Inc
SIBN

62 hedge funds and large institutions have $298M invested in SI-BONE Inc in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 35 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 10

32% more capital invested

Capital invested by funds: $225M → $298M (+$72.7M)

4% more ownership

Funds ownership: 51.41% → 55.41% (+4%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less funds holding

Funds holding: 66 → 62 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
62
Holders Change
-4
Holders Change %
-6.06%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
5
Increased
35
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$9.53M
2
ECM
Endurant Capital Management
California
+$8.44M
3
NCGI
Next Century Growth Investors
Minnesota
+$6.71M
4
Deutsche Bank
Deutsche Bank
Germany
+$3.68M
5
Victory Capital Management
Victory Capital Management
Texas
+$2.2M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$7.46M
2
Morgan Stanley
Morgan Stanley
New York
-$4.22M
3
Goldman Sachs
Goldman Sachs
New York
-$3.97M
4
BC
Broadfin Capital
New York
-$3.95M
5
AR
Advisory Research
Illinois
-$681K
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$130K – – –
JP Morgan Chase
52
JP Morgan Chase
New York
$114K +$556 +31 +0.6%
PO
53
Private Ocean
California
$112K -$22.4K -1,250 -19%
LF
54
Lee Financial
Texas
$80K – – –
Legal & General Group
55
Legal & General Group
United Kingdom
$71K +$11K +612 +23%
Citigroup
56
Citigroup
New York
$71K +$34.7K +1,936 +144%
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$50.8K +$843 +47 +2%
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
$45K +$12.3K +685 +48%
AIP
59
Ameritas Investment Partners
Nebraska
$30K – – –
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$28K +$21.6K +1,203 +1,322%
AF
61
Advisornet Financial
Minnesota
$24K +$15K +838 +279%
PCM
62
Prelude Capital Management
New York
$17K +$14.4K +800 New
O
63
OrbiMed
New York
– -$7.46M -422,000 Closed
BC
64
Broadfin Capital
New York
– -$3.95M -223,291 Closed
AR
65
Advisory Research
Illinois
– -$681K -38,542 Closed
EGM
66
Engineers Gate Manager
New York
– -$341K -19,285 Closed
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
– -$243K -13,778 Closed
GIP
68
Granite Investment Partners
California
– -$230K -13,009 Closed
HSBC Holdings
69
HSBC Holdings
United Kingdom
– -$202K -11,430 Closed
OAM
70
Oxford Asset Management
United Kingdom
– -$185K -10,495 Closed
TRCT
71
Tower Research Capital (TRC)
New York
– -$21K -1,180 Closed
1 2
3

SIBN Hedge Fund Activity: Q4 2019 in Review

62 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in SI-BONE Inc (SIBN) for Q4 2019, worth a combined $298M — up 32% from $225M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of SIBN and 5 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 35 added.

The largest buyer was Millennium Management, adding an estimated $9.53M. The largest seller was OrbiMed, exiting entirely with an estimated $7.46M sold.

  • 62 institutional investors held SI-BONE Inc (SIBN) as of Q4 2019, down from 66 in Q3 2019.
  • Funds reported $298M of SI-BONE Inc stock for Q4 2019, up 32% quarter-over-quarter.
  • 5 funds opened new SI-BONE Inc positions in Q4 2019 and 9 closed out, a net change of -4 holders.
  • The largest SI-BONE Inc buyer in Q4 2019 was Millennium Management, an estimated $9.53M added.
  • The largest SI-BONE Inc seller in Q4 2019 was OrbiMed, an estimated $7.46M sold.

Based on aggregated 13F filings for Q4 2019.